fosphenytoin sodium
Generic: fosphenytoin sodium
Labeler: gland pharma limitedDrug Facts
Product Profile
Brand Name
fosphenytoin sodium
Generic Name
fosphenytoin sodium
Labeler
gland pharma limited
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
fosphenytoin sodium 50 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
68083-460
Product ID
68083-460_00f57b3c-3819-440e-a928-eeec0fee27aa
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214926
Listing Expiration
2026-12-31
Marketing Start
2023-10-13
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68083460
Hyphenated Format
68083-460
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fosphenytoin sodium (source: ndc)
Generic Name
fosphenytoin sodium (source: ndc)
Application Number
ANDA214926 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/mL
Packaging
- 25 VIAL, SINGLE-DOSE in 1 CARTON (68083-460-25) / 2 mL in 1 VIAL, SINGLE-DOSE (68083-460-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "00f57b3c-3819-440e-a928-eeec0fee27aa", "openfda": {"upc": ["0368083461010", "0368083461102", "0368083460259"], "unii": ["7VLR55452Z"], "rxcui": ["1670195", "1670200"], "spl_set_id": ["49b08648-6a83-42c7-ae7b-80c29f2534fc"], "manufacturer_name": ["Gland Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (68083-460-25) / 2 mL in 1 VIAL, SINGLE-DOSE (68083-460-01)", "package_ndc": "68083-460-25", "marketing_start_date": "20231013"}], "brand_name": "Fosphenytoin sodium", "product_id": "68083-460_00f57b3c-3819-440e-a928-eeec0fee27aa", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68083-460", "generic_name": "Fosphenytoin sodium", "labeler_name": "Gland Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosphenytoin sodium", "active_ingredients": [{"name": "FOSPHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA214926", "marketing_category": "ANDA", "marketing_start_date": "20231013", "listing_expiration_date": "20261231"}